Loading...
Receive $200 for creating an Interactive Brokers account using our link: Create IBKR account. Read our Interactive Brokers analysis
- Ticker
- VERU
- Price
- 2.35
- Stock movement up
- +0.06 (2.62%)
- Company name
- Veru Inc
- Exchange
- (NASDAQ ,
- Currency
- USD )
- Sector
- Healthcare >Biotechnology
- Market cap
- 37.72M
- Ent value
- 15.17M
- Price/Sales
- -
- Price/Book
- 2.06
- Div yield
- 11914.89%
- Div growth
- -
- Growth years
- 2
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- -64.73%
- 1 year return (CAGR)
- -55.28%
- 3 year return (CAGR)
- -61.03%
- 5 year return (CAGR)
- -58.58%
- 10 year return (CAGR)
- -17.73%
Last updated: 2026-02-20
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
DIVIDENDS
Dividend yield - 5y
Loading...
Dividend yield data
| Dividend per share | 280.00 |
| Dividend yield | 11914.89% |
| Payout frequency | Quarterly |
| Maximum yield | 13084.11% |
| Average yield | 987.28% |
| Minimum yield | 1.18% |
| Discount to avg yield | 91.71% |
| Upside potential | 1106.84% |
| Yield as % of max yield | 91.06% |
Yield distribution (inverse percentile) - 5y
Loading...
Yield distribution data
| Dividend yield | 11914.89% |
| Current yield distribution | 1.90% |
| Yield at 100% (Min) | 1.18% |
| Yield at 90% | 2.34% |
| Yield at 80% | 3.28% |
| Yield at 50% (Median) | 24.56% |
| Yield at 20% | 49.12% |
| Yield at 10% | 793.65% |
| Yield at 0% (Max) | 13084.11% |
Dividend per share
Loading...
Dividend per share data
| Years of growth | 2 years |
| CCC status | - |
| Dividend per share | 280.00 |
| Payout frequency | Quarterly |
| Ex-div date | 28 Apr 2014 |
| EPS (TTM) | -1.55 |
| EPS (1y forward) | -1.72 |
| EPS growth (5y) | -64.73% |
| EPS growth (5y forward) | - |
Dividend growth
Loading...
Please create a free account or log in to access this chart
Dividend growth data
| VERU | S&P500 | |
| DGR MR | 16.67% | -13.74% |
| DGR TTM | 12.00% | 6.60% |
| DGR 3 years | - | 7.31% |
| DGR 5 years | - | 4.69% |
| DGR 10 years | - | 6.30% |
| DGR 15 years | - | 8.16% |
| Time since last change announced | 4717 days |
| EPS growth (5y) | -64.73% |
| EPS growth (5y forward) | - |
Payout ratio
Loading...
Please create a free account or log in to access this chart
Payout ratio data
| EPS coverage | FCF coverage | |
| TTM | - | - |
| Average | - | - |
| Forward | -16279.07% | - |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | - |
| Price to Book | 2.06 |
| EV to Sales | - |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 16.05M |
| EPS (TTM) | -1.55 |
| FCF per share (TTM) | -2.05 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 0.00 |
| Gross profit (TTM) | -123.53K |
| Operating income (TTM) | -33.38M |
| Net income (TTM) | -22.73M |
| EPS (TTM) | -1.55 |
| EPS (1y forward) | -1.72 |
Margins
Loading...
Margins data
| Gross margin (TTM) | - |
| Operating margin (TTM) | - |
| Profit margin (TTM) | - |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 32.99M |
| Net receivables | 0.00 |
| Total current assets | 36.81M |
| Goodwill | 6.88M |
| Intangible assets | 0.00 |
| Property, plant and equipment | 3.71M |
| Total assets | 47.57M |
| Accounts payable | 1.52M |
| Short/Current long term debt | 2.98M |
| Total current liabilities | 7.13M |
| Total liabilities | 10.44M |
| Shareholder's equity | 18.33M |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | -30.04M |
| Capital expenditures (TTM) | 1.08K |
| Free cash flow (TTM) | -30.04M |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | -123.97% |
| Return on Assets | -76.17% |
| Return on Invested Capital | -119.04% |
| Cash Return on Invested Capital | -157.37% |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 2.29 |
| Daily high | 2.45 |
| Daily low | 2.27 |
| Daily Volume | 62K |
| All-time high | 23780.00 |
| 1y analyst estimate | 25.00 |
| Beta | -1.49 |
| EPS (TTM) | -1.55 |
| Dividend per share | 280.00 |
| Ex-div date | 28 Apr 2014 |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| VERU | S&P500 | |
| Current price drop from All-time high | -99.99% | -1.82% |
| Highest price drop | -99.99% | -56.47% |
| Date of highest drop | 31 Dec 2025 | 9 Mar 2009 |
| Avg drop from high | -54.23% | -10.84% |
| Avg time to new high | 83 days | 12 days |
| Max time to new high | 1920 days | 1805 days |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
COMPANY DETAILS
Marketcap
37.72M
Marketcap category
Small-cap
Description
Veru Inc., a late clinical stage biopharmaceutical company, focuses on developing medicines for treatment of metabolic diseases, oncology, and viral-induced acute respiratory distress syndrome (ARDS) in Florida and internationally. It provides FC2 female condom for the dual protection against unplanned pregnancy and the transmission of sexually transmitted infections. The company develops enobosarm, a selective androgen receptor modulator for treatment of augment fat loss and to prevent muscle loss in sarcopenic obese and overweight elderly patients; Enobosarm, an oral selective androgen receptor modulator for the treatment of AR+ ER+ HER2- metastatic breast cancer; and sabizabulin, a microtubule disruptor for the treatment of hospitalized patients with viral lung infection at high risk for viral induced ARDS and death. The company was formerly known as The Female Health Company and changed its name to Veru Inc. in July 2017. Veru Inc. was incorporated in 1971 and is headquartered in Miami, Florida.
Employees
20
Website
Investor relations
-
SEC filings
CEO
Mitchell Shuster Steiner
Country
USA
City
Miami
Stock type
Common stock
CCC status
-
Dividend Frequency
Quarterly
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
Seeking AlphaPress releases
iO Charts is a Seeking Alpha partnerNext page